Please login to the form below

Not currently logged in
Email:
Password:

Bedgebury win Levemir account

Bedgebury Communications has been appointed by Novo Nordisk to work on the Levemir UK advertising account

Bedgebury Communications has been appointed by Novo Nordisk to work on the Levemir (insulin detemir [rDNA origin] injection) UK advertising account.

Commenting on the recent win, John Russell, Director at Bedgebury Communications, said: "We are delighted to be working with Novo Nordisk on this exciting brand and are confident that our creativity, strategic capabilities, market insight and unrivalled attitude to service will help us to deliver real value to Levemir."

Bedgebury focuses on offering a results-lead communications service, encompassing strategy development, origination and execution of creative concepts and med-ed programmes designed to address key market opportunities.

30th September 2009

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics